BROADCASTS.com

Every week, The American Journal of Managed Care\xae recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.\n\nThis week, the top managed care stories included another report that shows uninsured rates are rising; FDA confirms shortages of the EpiPen, but the manufacturer insists the delay will be short;\xa0a Senate panel examines the need for transparency in insulin pricing.\n\nRead more about the stories in this podcast:\nNo States Reported a Decline in the Uninsured Rate From 2016 to 2017:\xa0www.ajmc.com/focus-of-the-week/no-states-reported-a-decline-in-the-uninsured-rate-from-2016-to-2017\nFDA Confirms Short-Term Shortages of EpiPen: www.ajmc.com/newsroom/fda-confirms-shortterm-shortages-of-epipen\nADA's Cefalu Calls for Transparency Across Supply Chain to Address Insulin Costs: www.ajmc.com/newsroom/adas-cefalu-calls-for-transparency-across-supply-chain-to-address-insulin-costs\nDaratumumab Approved as Frontline Treatment in Newly Diagnosed Multiple Myeloma: www.ajmc.com/newsroom/daratumumab-approved-as-frontline-treatment-in-newly-diagnosed-multiple-myeloma\nSingle-Payer System Is the Solution for Mental Health Care, Panelists Say: www.ajmc.com/conferences/apa-2018/singlepayer-system-is-the-solution-for-mental-health-care-panelists-say\nAmerican Psychiatric Association 2018 Annual Meeting: www.ajmc.com/conferences/apa-2018